Surgeons should consider local therapies for recurrent pancreatic ductal adenocarcinoma as they show significant survival benefits.
- For liver-only recurrence, local therapy leads to longer survival than chemotherapy alone (HR 0.26).
- Surgical resection for lung-only recurrence offers better survival compared to conventional treatment (HR 0.35).
Careful patient selection and tailored approaches could enhance outcomes in recurrence management.
- Locoregional resection also correlates with increased survival (HR 0.52).
Journal Article by Maekawa A, Perri G (…) Marchegiani G et 6 al. in Ann Surg Oncol
© 2026. The Author(s).